316 related articles for article (PubMed ID: 23308247)
1. The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling.
Desel C; Werninghaus K; Ritter M; Jozefowski K; Wenzel J; Russkamp N; Schleicher U; Christensen D; Wirtz S; Kirschning C; Agger EM; Prazeres da Costa C; Lang R
PLoS One; 2013; 8(1):e53531. PubMed ID: 23308247
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate.
Schoenen H; Bodendorfer B; Hitchens K; Manzanero S; Werninghaus K; Nimmerjahn F; Agger EM; Stenger S; Andersen P; Ruland J; Brown GD; Wells C; Lang R
J Immunol; 2010 Mar; 184(6):2756-60. PubMed ID: 20164423
[TBL] [Abstract][Full Text] [Related]
3. Contribution of MINCLE-SYK Signaling to Activation of Primary Human APCs by Mycobacterial Cord Factor and the Novel Adjuvant TDB.
Ostrop J; Jozefowski K; Zimmermann S; Hofmann K; Strasser E; Lepenies B; Lang R
J Immunol; 2015 Sep; 195(5):2417-28. PubMed ID: 26202982
[TBL] [Abstract][Full Text] [Related]
4. Monocytes Elicit a Neutrophil-Independent Th1/Th17 Response Upon Immunization With a Mincle-Dependent Glycolipid Adjuvant.
Desel C; Murray PJ; Lehmann CHK; Heger L; Christensen D; Andersen P; Mack M; Dudziak D; Lang R
Front Immunol; 2022; 13():880474. PubMed ID: 35585969
[TBL] [Abstract][Full Text] [Related]
5. Differential control of Mincle-dependent cord factor recognition and macrophage responses by the transcription factors C/EBPβ and HIF1α.
Schoenen H; Huber A; Sonda N; Zimmermann S; Jantsch J; Lepenies B; Bronte V; Lang R
J Immunol; 2014 Oct; 193(7):3664-75. PubMed ID: 25156364
[TBL] [Abstract][Full Text] [Related]
6. Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome.
Shenderov K; Barber DL; Mayer-Barber KD; Gurcha SS; Jankovic D; Feng CG; Oland S; Hieny S; Caspar P; Yamasaki S; Lin X; Ting JP; Trinchieri G; Besra GS; Cerundolo V; Sher A
J Immunol; 2013 Jun; 190(11):5722-30. PubMed ID: 23630357
[TBL] [Abstract][Full Text] [Related]
7. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation.
Werninghaus K; Babiak A; Gross O; Hölscher C; Dietrich H; Agger EM; Mages J; Mocsai A; Schoenen H; Finger K; Nimmerjahn F; Brown GD; Kirschning C; Heit A; Andersen P; Wagner H; Ruland J; Lang R
J Exp Med; 2009 Jan; 206(1):89-97. PubMed ID: 19139169
[TBL] [Abstract][Full Text] [Related]
8. IL-4 and helminth infection downregulate MINCLE-dependent macrophage response to mycobacteria and Th17 adjuvanticity.
Schick J; Altunay M; Lacorcia M; Marschner N; Westermann S; Schluckebier J; Schubart C; Bodendorfer B; Christensen D; Alexander C; Wirtz S; Voehringer D; da Costa CP; Lang R
Elife; 2023 Feb; 12():. PubMed ID: 36753434
[TBL] [Abstract][Full Text] [Related]
9. The mycobacterial cord factor adjuvant analogue trehalose-6,6'-dibehenate (TDB) activates the Nlrp3 inflammasome.
Schweneker K; Gorka O; Schweneker M; Poeck H; Tschopp J; Peschel C; Ruland J; Gross O
Immunobiology; 2013 Apr; 218(4):664-73. PubMed ID: 22921586
[TBL] [Abstract][Full Text] [Related]
10. C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation.
Zhao XQ; Zhu LL; Chang Q; Jiang C; You Y; Luo T; Jia XM; Lin X
J Biol Chem; 2014 Oct; 289(43):30052-62. PubMed ID: 25202022
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.
Davidsen J; Rosenkrands I; Christensen D; Vangala A; Kirby D; Perrie Y; Agger EM; Andersen P
Biochim Biophys Acta; 2005 Dec; 1718(1-2):22-31. PubMed ID: 16321607
[TBL] [Abstract][Full Text] [Related]
12. Rational design of adjuvants targeting the C-type lectin Mincle.
Decout A; Silva-Gomes S; Drocourt D; Barbe S; André I; Cueto FJ; Lioux T; Sancho D; Pérouzel E; Vercellone A; Prandi J; Gilleron M; Tiraby G; Nigou J
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2675-2680. PubMed ID: 28223515
[TBL] [Abstract][Full Text] [Related]
13. Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivo.
Huber A; Kallerup RS; Korsholm KS; Franzyk H; Lepenies B; Christensen D; Foged C; Lang R
Innate Immun; 2016 Aug; 22(6):405-18. PubMed ID: 27252171
[TBL] [Abstract][Full Text] [Related]
14. Neutrophils Promote Mycobacterial Trehalose Dimycolate-Induced Lung Inflammation via the Mincle Pathway.
Lee WB; Kang JS; Yan JJ; Lee MS; Jeon BY; Cho SN; Kim YJ
PLoS Pathog; 2012; 8(4):e1002614. PubMed ID: 22496642
[TBL] [Abstract][Full Text] [Related]
15. Mincle is not essential for controlling Mycobacterium tuberculosis infection.
Heitmann L; Schoenen H; Ehlers S; Lang R; Hölscher C
Immunobiology; 2013 Apr; 218(4):506-16. PubMed ID: 22784441
[TBL] [Abstract][Full Text] [Related]
16. Toll like-receptor agonist Pam
Kennerknecht K; Noschka R; Löffler F; Wehrstedt S; Pedersen GK; Mayer D; Grieshober M; Christensen D; Stenger S
Med Microbiol Immunol; 2020 Apr; 209(2):163-176. PubMed ID: 32020284
[TBL] [Abstract][Full Text] [Related]
17. C-type lectin MCL is an FcRγ-coupled receptor that mediates the adjuvanticity of mycobacterial cord factor.
Miyake Y; Toyonaga K; Mori D; Kakuta S; Hoshino Y; Oyamada A; Yamada H; Ono K; Suyama M; Iwakura Y; Yoshikai Y; Yamasaki S
Immunity; 2013 May; 38(5):1050-62. PubMed ID: 23602766
[TBL] [Abstract][Full Text] [Related]
18. Species-Specific Structural Requirements of Alpha-Branched Trehalose Diester Mincle Agonists.
Smith AJ; Miller SM; Buhl C; Child R; Whitacre M; Schoener R; Ettenger G; Burkhart D; Ryter K; Evans JT
Front Immunol; 2019; 10():338. PubMed ID: 30873180
[TBL] [Abstract][Full Text] [Related]
19. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
[TBL] [Abstract][Full Text] [Related]
20. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
